Hypercapnic Respiratory Failure
43
2
2
21
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.0%
3 terminated out of 43 trials
87.5%
+1.0% vs benchmark
9%
4 trials in Phase 3/4
5%
1 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (43)
Efficacy of Volume Ventilation in Patients With Acute Respiratory Failure at Risk of Obstructive Apneas or Obesity Hypoventilation
Information-Motivation-Behavioral Skills Model-based Intervention to Domiciliary Non-invasive Ventilation of Patients
Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor
Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome
Transcutaneous CO2 Measurement - From Hospital to Home
Clinical Stabilization of Hypercapnia: NIPPV v HVNI
Remote Monitoring to Improve Low Adherence in Non-invasive Ventilation
Evaluation of Conventional Non-invasive Mechanical Ventilation (NIV) Versus an Automatic Ventilation Mode.
Treatment of Acute Hypercapnic Respiratory Failure With OptiflowTM or Optiflow+DuetTM Nasal Cannula in COPD-patients
Novel ECCO2R Device for Hypercapnic Respiratory Failure
NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP
Optimal Timing and Failure Prediction of High Flow Nasal Cannula Oxygen Therapy in Emergency Department: Prospective Observational Single Center Study
Use of Nasal High Flow Oxygen During Breaks of Non-invasive Ventilation for Patients With Hypercapnic Respiratory Failure
Mathematically Arterialised Testing of Hypercapnic Subjects Study
Conventional Low Flow Oxygenation Versus High Flow Nasal Cannula in Hypercapnic Respiratory Failure
Ketogenic Diet for Obesity Hypoventilation Syndrome
NHF vs. COT in Hypoxemic Pandemic Viral Illness
Clinical Evaluation of COPD Butler in Patient Home Management
Weaning From Noninvasive Ventilation
High-flow Air Via Nasal Cannula vs Non-invasive Continuous Positive Airway Pressure for Hypercapnic Respiratory Failure